Industrials · Services-Business Services, NEC · Nasdaq · CIK 1448431 · FYE Dec 31 · Prices AT CLOSE 2026-08-21 (USD) Last $7.71 · Day −3.14% · Mkt cap $145M · P/E (FY) 28.6× · 1Y −52.2% · Off 52W high −65.3% · Vol (1Y) 74.3% Price2023-08-21 → 2026-08-21 OPRX close: $8.0 on 2023-08-21 to $7.7 on 2026-08-21. Split-adj closes · 240 of 3,779 · price returnⓘ At a glance | Short interest7.2% of sh out | | Days to cover6.3d | | 13F net flow (QoQ)+4.77% | | Top-10 13F concentration57.9% | | Next report (est.)2026-11-11 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | P/E (FY)28.6× | | Sales (TTM)$98.7M | | Earnings (TTM)$4.6M | | ROE4.2% | | Net margin4.7% | | ROIC6.5% | | Debt / equity0.20× | | Total debt / EBITDA1.60× | | Sales growth 3Y20.6% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−37.1% | | 1Y−52.2% | | 3Y−3.6% | | 5Y−87.5% | | 10Y+117.8% | | Since incept. (ann.)+4.1% |
Total return · from 2011-07-11ⓘ Risk | Ann. volatility (1Y)74.3% | | Ann. volatility (3Y)81.5% | | Sharpe (1Y)−0.58 | | Sharpe (3Y)0.38 | | Max drawdown (1Y)−79.1% | | Max drawdown (3Y)−79.1% | | Beta (3Y vs SPY)1.06 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Whetstone Capital Advisors, LLC | 1.5M | $9M | 8.04% | +0.0% | | BlackRock, Inc. | 1.2M | $7M | 6.20% | −2.6% | | ROYCE & ASSOCIATES LP | 888,030 | $6M | 4.73% | +30.2% | | Parkman Healthcare Partners LLC | 729,369 | $5M | 3.89% | +35.4% | | VANGUARD CAPITAL MANAGEMENT LLC | 685,449 | $4M | 3.65% | new | | KENNEDY CAPITAL MANAGEMENT LLC | 656,258 | $4M | 3.50% | −2.6% | | BLAIR WILLIAM & CO/IL | 614,992 | $4M | 3.28% | +5.6% | | RICE HALL JAMES & ASSOCIATES, LLC | 601,921 | $4M | 3.21% | +1.9% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-12 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-12 | −$0.04 | −150.0% | $20.5M | −29.8% | | 2026-03-31 | 2026-05-12 | −$0.03 | — | $19.8M | −9.5% | | 2025-12-31 | 2026-03-05 | $0.27 | — | $32.2M | −0.2% | | 2025-09-30 | 2025-11-06 | $0.04 | — | $26.1M | +22.3% |
As-reported XBRL · next 2026-11-11 est.ⓘ Segment mixFY2025 (ended Dec 2025) Life Science Companies 100% · Other Revenue 0% product & service · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
